16.75
Schlusskurs vom Vortag:
$16.59
Offen:
$16.79
24-Stunden-Volumen:
140.99K
Relative Volume:
0.07
Marktkapitalisierung:
$2.74B
Einnahmen:
$5.07B
Nettoeinkommen (Verlust:
$-306.00M
KGV:
-7.7189
EPS:
-2.17
Netto-Cashflow:
$-70.00M
1W Leistung:
-4.57%
1M Leistung:
+0.97%
6M Leistung:
+22.15%
1J Leistung:
-44.08%
Rxo Inc Stock (RXO) Company Profile
Firmenname
Rxo Inc
Sektor
Branche
Telefon
704-572-7302
Adresse
11215 NORTH COMMUNITY HOUSE ROAD, CHARLOTTE
Vergleichen Sie RXO mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
RXO
Rxo Inc
|
16.73 | 2.72B | 5.07B | -306.00M | -70.00M | -2.17 |
![]()
ODFL
Old Dominion Freight Line Inc
|
136.56 | 28.23B | 5.64B | 1.10B | 780.91M | 5.1201 |
![]()
XPO
Xpo Inc
|
130.98 | 15.24B | 8.01B | 346.00M | 151.00M | 2.89 |
![]()
SAIA
Saia Inc
|
299.32 | 7.84B | 3.17B | 375.19M | -394.01M | 14.00 |
![]()
TFII
Tfi International Inc
|
88.10 | 7.18B | 8.29B | 469.99M | 696.54M | 5.49 |
![]()
KNX
Knight Swift Transportation Holdings Inc
|
42.72 | 6.88B | 7.48B | 37.47M | 2.37M | 0.23 |
Rxo Inc Stock (RXO) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-04-04 | Herabstufung | Oppenheimer | Outperform → Perform |
2025-03-13 | Eingeleitet | Truist | Buy |
2025-03-07 | Eingeleitet | Deutsche Bank | Hold |
2024-11-18 | Fortgesetzt | Goldman | Neutral |
2024-11-12 | Herabstufung | Citigroup | Buy → Neutral |
2024-11-11 | Fortgesetzt | Wells Fargo | Equal Weight |
2024-10-09 | Eingeleitet | Citigroup | Buy |
2024-05-15 | Fortgesetzt | Raymond James | Mkt Perform |
2024-05-03 | Bestätigt | TD Cowen | Hold |
2024-02-09 | Bestätigt | TD Cowen | Market Perform |
2024-02-08 | Herabstufung | BofA Securities | Buy → Neutral |
2024-01-10 | Herabstufung | Vertical Research | Buy → Hold |
2023-10-11 | Herabstufung | JP Morgan | Neutral → Underweight |
2023-08-31 | Herabstufung | Susquehanna | Neutral → Negative |
2023-07-12 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
2023-06-09 | Eingeleitet | Susquehanna | Neutral |
2023-05-24 | Eingeleitet | Barclays | Overweight |
2023-04-04 | Eingeleitet | The Benchmark Company | Hold |
2023-02-27 | Eingeleitet | Cowen | Market Perform |
2023-01-11 | Herabstufung | Stifel | Buy → Hold |
2023-01-09 | Eingeleitet | JP Morgan | Neutral |
2022-12-20 | Eingeleitet | Wells Fargo | Equal Weight |
2022-12-09 | Eingeleitet | Morgan Stanley | Equal-Weight |
2022-12-09 | Eingeleitet | UBS | Neutral |
2022-12-06 | Eingeleitet | Jefferies | Buy |
2022-12-05 | Eingeleitet | Raymond James | Mkt Perform |
2022-11-30 | Eingeleitet | BofA Securities | Buy |
2022-11-22 | Eingeleitet | Goldman | Neutral |
2022-11-22 | Eingeleitet | Oppenheimer | Outperform |
2022-11-21 | Eingeleitet | Vertical Research | Buy |
2022-11-10 | Eingeleitet | Wolfe Research | Peer Perform |
Alle ansehen
Rxo Inc Aktie (RXO) Neueste Nachrichten
Will RXO Inc. (N9Q) stock outperform small cap peersJuly 2025 Action & AI Enhanced Trading Alerts - newser.com
Should you hold or exit RXO Inc. now2025 Trade Ideas & Real-Time Stock Price Movement Reports - newser.com
Is RXO Inc. stock positioned for digital transformationOptions Play & Risk Controlled Stock Pick Alerts - newser.com
Is RXO Inc. stock poised for growthJuly 2025 Selloffs & Low Volatility Stock Recommendations - newser.com
RXO, Inc. Experiences Revision in Stock Evaluation Amid Mixed Performance Indicators - Markets Mojo
Forecasting RXO Inc. price range with options dataPortfolio Risk Report & Safe Entry Trade Signal Reports - newser.com
RXO (NYSE:RXO) Price Target Lowered to $15.00 at The Goldman Sachs Group - MarketBeat
Strategies to average down on RXO Inc.July 2025 Retail & Safe Capital Investment Plans - newser.com
Will RXO Inc. (N9Q) stock return to pre crash levelsJuly 2025 Outlook & Stepwise Entry/Exit Trade Alerts - newser.com
Stifel Raises Price Target for RXO to $17, Maintains Hold Rating - GuruFocus
Stifel raises RXO stock price target to $17 from $14, maintains Hold rating - Investing.com
How RXO Inc. stock stacks up against competitorsWeekly Risk Summary & Step-by-Step Trade Execution Guides - newser.com
How cyclical is RXO Inc. (N9Q) stock compared to rivalsPortfolio Gains Summary & Free Expert Verified Stock Movement Alerts - newser.com
Goldman Sachs Maintains RXO (RXO) Neutral Recommendation - Nasdaq
RXO, Inc. Hits Day High with Strong 7.52% Intraday Surge - Markets Mojo
Goldman Sachs Lowers Price Target for RXO to $15, Maintains Neut - GuruFocus
Is a relief rally coming for RXO Inc. holdersMarket Sentiment Summary & Daily Price Action Insights - newser.com
Why RXO Inc. stock is trending on social media2025 Year in Review & Fast Gain Stock Trading Tips - newser.com
How RXO Inc. stock gains from tech spending2025 Year in Review & Risk Controlled Swing Trade Alerts - newser.com
How high can RXO Inc. stock goDollar Strength & Free Reliable Trade Execution Plans - newser.com
RXO's (RXO) Sell (D-) Rating Reiterated at Weiss Ratings - MarketBeat
What analysts say about RXO Inc stockVolume Profile Analysis & Investment Risk Management Tips - earlytimes.in
JP Morgan Maintains RXO (RXO) Underweight Recommendation - Nasdaq
JPMorgan Chase & Co. Issues Positive Forecast for RXO (NYSE:RXO) Stock Price - MarketBeat
RXO Analyst Rating: JP Morgan Raises Price Target to $16 | RXO S - GuruFocus
Why RXO, Inc. Stock is Gaining Momentum - TipRanks
J.P. Morgan Maintains RXO Inc(RXO.US) With Sell Rating, Raises Target Price to $16 - 富途牛牛
Werner, GXO Logistics, Heartland Express, RXO, and Schneider Shares Plummet, What You Need To Know - TradingView
BofA Securities Maintains RXO Inc(RXO.US) With Hold Rating, Raises Target Price to $18 - 富途牛牛
Rxo Inc (NYSE:RXO) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Morgan Stanley Maintains RXO Inc(RXO.US) With Hold Rating, Maintains Target Price $20 - 富途牛牛
RXO Schedules Third-Quarter Earnings and Investor Conference Call for November 6, 2025 - Business Wire
Technical signs of recovery in RXO Inc.July 2025 Highlights & Growth Oriented Trade Recommendations - newser.com
RXO INVESTIGATION: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
Is this a good reentry point in RXO Inc.2025 Big Picture & Technical Buy Zone Confirmation - newser.com
Forget Airlines—These Trucking Stocks Are Shifting Into High Gear - MarketBeat
UBS Maintains RXO (RXO) Neutral Recommendation - Nasdaq
Why RXO (RXO) Stock Is Trading Up Today - Barchart.com
UBS Adjusts RXO Price Target to $17 From $15, Maintains Neutral Rating - MarketScreener
UBS Maintains RXO Inc(RXO.US) With Hold Rating, Raises Target Price to $17 - 富途牛牛
Is RXO Inc. stock attractive for long term wealth buildingJuly 2025 Fed Impact & Smart Investment Allocation Tips - newser.com
Finanzdaten der Rxo Inc-Aktie (RXO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Rxo Inc-Aktie (RXO) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Firestone Jeffrey D. | Chief Legal Officer |
Aug 31 '25 |
Option Exercise |
0.00 |
17,262 |
0 |
89,763 |
Firestone Jeffrey D. | Chief Legal Officer |
Aug 22 '25 |
Option Exercise |
0.00 |
25,716 |
0 |
83,739 |
Szlosek Thomas A | Director |
May 14 '25 |
Buy |
16.65 |
7,500 |
124,875 |
16,200 |
Szlosek Thomas A | Director |
May 09 '25 |
Buy |
14.41 |
8,700 |
125,354 |
8,700 |
Wilkerson Andrew M. | Chief Executive Officer |
May 02 '25 |
Option Exercise |
0.00 |
92,932 |
0 |
312,379 |
Firestone Jeffrey D. | Chief Legal Officer |
Mar 22 '25 |
Option Exercise |
0.00 |
11,772 |
0 |
63,168 |
Kerr Jason S. | Chief Accounting Officer |
Mar 22 '25 |
Option Exercise |
0.00 |
2,030 |
0 |
87,307 |
HARRIS JAMES E | Chief Financial Officer |
Mar 22 '25 |
Option Exercise |
0.00 |
12,989 |
0 |
72,963 |
Wilkerson Andrew M. | Chief Executive Officer |
Mar 22 '25 |
Option Exercise |
0.00 |
52,769 |
0 |
242,508 |
Wilkerson Andrew M. | Chief Executive Officer |
Mar 10 '25 |
Option Exercise |
0.00 |
2,105 |
0 |
190,659 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):